Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice

被引:11
作者
Drutskaya, MS [1 ]
Ortiz, M
Liepinsh, DJ
Kuprash, DV
Nedospasov, SA
Keller, JR
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Mol Immunol, Moscow 119991, Russia
[2] Natl Canc Inst, Basic Res Program, SAIC Frederick, Frederick, MD USA
[3] Canc Res Ctr, Mol Immunoregulat Lab, Frederick, MD USA
关键词
D O I
10.1016/j.exphem.2005.08.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The effects of TNF deficiency on myelopoiesis were evaluated in long-term (LTBMC) and short-term bone marrow cultures (STBMC) and compared to hematopoietic activity in vivo in TNF-deficient mice. Methods. LTBMC and STBMC were established from bone marrow of TNF-deficient mice in the presence or absence of soluble TNF. Total cell production was measured over time, as well as the number of colony-forming units in culture (CFU-C). Morphology of nonadherent (NA) cells in LTBMC was assessed after 10 weeks. Bone marrow cells (BMC) and peripheral blood (PB) cells were used to determine lineage distribution within the hematopoietic system. BMC were sorted to obtain Lin(-)c-kit(+)Sca-1(-) and Lin(-)c-kit(+)Sca-1(+) cells, which were plated in semisolid media to determine CFU-C numbers or injected into irradiated recipients to determine colony formation in the spleen (CFU-S). Results. TNF-deficient LTBMC and STBMC show increased proliferative capacity, which can be inhibited by exogenous TNF to wild-type levels. Morphological analysis of NA cells from TNF-deficient LTBMC revealed increased numbers of cells at early stages of granulocytic differentiation (myeloblasts/promyelocytes) paralleled by a sharp decrease in the number of terminally differentiated polymorphonuclear neutrophils. Slightly elevated numbers of leukocytes, mainly neutrophils, were detected in PB of TNF-deficient mice. In. bone marrow of TNF-deficient mice a significant increase in the number of both CFU-GM within Lin(-)c-kit(+)Sca-1(-) population and CFU-S within Lin-c-kit+Sca-l+ population was observed. Conclusions. TNF has inhibitory effects on granulocyte-macrophage progenitors in vitro and on committed and primitive hematopoietic progenitors in vivo. However, in adult organism TNF deficiency is mostly compensated and controlled. (c) 2005 International Society for Experimental Hematology.
引用
收藏
页码:1348 / 1356
页数:9
相关论文
共 42 条
[1]   Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo [J].
Abe, K ;
Yarovinsky, FO ;
Murakami, T ;
Shakhov, AN ;
Tumanov, AV ;
Ito, D ;
Drutskaya, LN ;
Pfeffer, K ;
Kuprash, DV ;
Komschlies, KL ;
Nedospasov, SA .
BLOOD, 2003, 101 (04) :1477-1483
[2]   Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial [J].
Antoni, C ;
Krueger, GG ;
de Vlam, K ;
Birbara, C ;
Beutler, A ;
Guzzo, C ;
Zhou, B ;
Dooley, LT ;
Kavanaugh, A .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1150-1157
[3]  
Baker Danial E, 2004, Rev Gastroenterol Disord, V4, P196
[4]   Autoimmunity and apoptosis: The Crohn's connection [J].
Beutler, B .
IMMUNITY, 2001, 15 (01) :5-14
[5]  
Beyaert R, 1998, CYTOKINES, P335, DOI 10.1016/B978-012498340-3/50025-7
[6]  
Bojarska-Junak A, 2002, HAEMATOLOGICA, V87, P490
[7]  
Branch DR, 1996, EXP HEMATOL, V24, P675
[8]   Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab [J].
Broussais, F ;
Kawashima, M ;
Marotte, H ;
Miossec, P .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) :509-510
[9]   Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration [J].
Brown, SL ;
Greene, MH ;
Gershon, SK ;
Edwards, ET ;
Braun, MM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3151-3158
[10]   Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation [J].
Bryder, D ;
Ramsfjell, V ;
Dybedal, I ;
Theilgaard-Mönch, K ;
Högerkorp, CM ;
Adolfsson, J ;
Borge, OJ ;
Jacobsen, SEW .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (07) :941-952